Summary
The primary replication of one strain of HSV was generally unaffected by the simultaneous inoculation of another strain either at the same site or at a different site within the same dermatome. Exceptions to this were the result of the generation of intertypic recombinants which were readily isolated only from sensory ganglia 5 and 6 days after inoculation with a mixture of HSV-1 and HSV-2 and from explant culture of the resultant latently infected ganglia. By restriction enzyme analysis the majority of the recombinant strains from primary infection were characterized as HSV 1; all those from latently infected ganglia were characterized as type 2.
Similar content being viewed by others
References
Blyth WA, Harbour DA, Hill TJ (1984) Pathogenesis of zosteriform spread of HSV in the mouse. J Gen Virol 65: 1477–1486
Darville JM (1983) Miniaturised and simplified technique for typing and subtyping HSV. J Clin Pathol 36: 929–934
Darville JM, Harbour DA, Hill TJ, Blyth WA (1987) Restriction endonuclease analysis of herpes simplex virus from recrudescent lesions, from latent infection and during passage in the skin and nervous system of mice. J Gen Virol 68: 907–911
Fife KH, Schmidt O, Remington M, Corey L (1983) Primary and recurrent concomitant genital infection with herpes simplex virus types 1 and 2. J Infect Dis 147: 163
Gerdes JC, Smith DS (1983) Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains. J Gen Virol 64: 2441–2454
Gerson M, Portnoy J, Hamelin C (1984) Consecutive infections with herpes simplex viruses types 1 and 2 within a three week pariod. J Infect Dis 149: 655
Glezen WP, Fernland GW, Lohr JA (1975) Acute respiratory disease of university students with special reference to the etiologic role of herpesvirus hominis. Am J Epidemiol 101: 111–121
Halliburton IW, Honess RW, Killington RA (1987) Virulence is not conserved in recombinants between herpes simplex viruses types 1 and 2. J Gen Virol 68: 1435–1440
Hill TJ, Field HJ, Blyth WA (1975) Acute and recurrent infection with HSV in the mouse: a model for studying latency and recurrent disease. J Gen Virol 28: 341–353
Javier RT, Sedarati F, Stevens JG (1986) Two avirulent herpes simplex viruses generate lethal recombinants in vivo. Science 234: 746–748
Kit S, Trkula D, Qavi H, Dreesman G, Kennedy RC, Alder-Storthz K, Kaufman R, Adam E (1983) Sequential genital infections by herpes simplex viruses types 1 and 2: restriction nuclease analysis of viruses from recurrent infections. Sex Transm Dis 10: 67–71
Lewis ME, Leung WC, Jeffrey VM, Warren KG (1984) Detection of multiple strains of latent herpes simplex virus type 1 within individual human hosts. J Virol 52: 300–305
Maitland NJ, Smith IW, Peutherer JF, Robertson DHH, Jones KW (1982) Restriction endonuclease analysis of DNA from genital isolates of herpes simplex virus type 2. Infect Immun 38: 834–842
Reeves WC, Corey L, Adams HG, Vontver LA, Holmes KK (1981) Risk of recurrence after first episodes of genital herpes: relation to HSV type and antibody response. N Engl J Med 305: 315–319
Roller NW (1983) Primary herpetic gingivostomatitis in the adult. Gen Dentist 31: 101–103
Vahlne A, Svennerholm B, Lycke E (1979) Evidence for herpes simplex virus type-specific receptors on cellular plasma membranes. J Gen Virol 44: 217–225
Wolff MH, Kramer S, Schneweis KE (1986) Does restriction enzyme analysis reveal changes in herpes simplex virus DNA after latency in mouse ganglia? Microbiologica 9: 139–145
Yirrell DL, Blyth WA, Hill TJ, Rogers CE (1990) Heterotypic and homotypic reinoculation of mice already latently infected with herpes simplex virus type 1. Arch Virol 110: 25–36
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yirrell, D.L., Rogers, C.E., Blyth, W.A. et al. Experimental in vivo generation of intertypic recombinant strains of HSV in the mouse. Archives of Virology 125, 227–238 (1992). https://doi.org/10.1007/BF01309640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01309640